Found 5 matching trials
A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
PHASE2A double-blind, placebo-controlled, parallel-group study to assess the safe...
Open Label Extension
PHASE3TRES will evaluate the effects of continued ALX1-11 treatment on the safety...
Location
'Osteoporosis Medical Center
Calcium Supplementation in Postmenopausal Women
PHASE3This study is evaluating the effects of calcium supplementation on the effi...
Location
'Boling Clinical Trials
Open Label Extension Study of PREOS
PHASE3This is an Open Label Extension Study (OLES) for patients who participated ...
Location
'The University of Alabama at Birmingham
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
PHASE3This is an 18-month, double-blind, placebo-controlled, Phase III trial with...
Location
Capstone Clinical Trials